Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

ANGLE says five-year study identifies the “key advantages” of the company’s liquid biopsy system

% of readers think this story is Fact. Add your two cents.


ANGLE PLC (LON:AGL, OTCQX:ANPCY) said a five-year study of five circulating tumour cell (CTC) isolation platforms identified the “key advantages” of the company’s liquid biopsy system.

The research showed that Parsortix’s performance was “robust”, with mean cell capture rates of 71% and 67% for the two cell types targeted.

The leading US-approved antibody-based CTC system was unable to enrich one particular line, called EpCAM low cells.

Parsortix was comparable to the leading antibody-based system in terms of time required for sample processing, staining and cell identification and was “considerably faster” than some other systems.

ANGLE said the Transfix blood collection tubes, used with Parsortix in this study, provided for five days’ blood stability “enhancing the practicability of sample management”.

The platform was assessed as part of work undertaken by the CANCER-ID Consortium, a public-private partnership supported by Europe’s Innovative Medicines Initiative.

Investigated was the ability of the devices to screen for non-small cell lung cancer CTCs.

ANGLE founder and chief executive, Andrew Newland, said: “We look forward to harnessing Parsortix’s unique capabilities as we continue to make strong progress with the establishment of approved clinical laboratories to support the use of the Parsortix system for pharma services and subsequent clinical deployment for clinical use.

“As previously announced, the Parsortix system has been submitted to FDA, seeking the first ever FDA product clearance for a system that harvests cancer cells from a simple blood draw for subsequent analysis.”

Story by ProactiveInvestors



Source: http://www.proactiveinvestors.com/companies/news/939825/angle-says-five-year-study-identifies-the-key-advantages-of-the-companys-liquid-biopsy-system-939825.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse
Loading...

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.